About

Log in?

DTU users get better search results including licensed content and discounts on order fees.

Anyone can log in and get personalized features such as favorites, tags and feeds.

Log in as DTU user Log in as non-DTU user No thanks

DTU Findit

Journal article

Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges

In Analyst 2021, Volume 146, Issue 12, pp. 3750-3776
From

Department of Biotechnology and Biomedicine, Technical University of Denmark1

Statens Serum Institut2

Universidad Industrial de Santander3

Section for Microbial and Chemical Ecology, Department of Biotechnology and Biomedicine, Technical University of Denmark4

The ongoing COVID-19 pandemic has shown the importance of having analytical devices that allow a simple, fast, and robust detection of pathogens which cause epidemics and pandemics. The information these devices can collect is crucial for health authorities to make effective decisions to contain the disease's advance.

The World Health Organization published a list of primary pathogens that have raised concern as potential causes of future pandemics. Unfortunately, there are no rapid diagnostic tests commercially available and approved by the regulatory bodies to detect most of the pathogens listed by the WHO. This report describes these pathogens, the available detection methods, and highlights areas where more attention is needed to produce rapid diagnostic tests for future pandemic surveillance.

Language: English
Publisher: The Royal Society of Chemistry
Year: 2021
Pages: 3750-3776
ISSN: 13645528 and 00032654
Types: Journal article
DOI: 10.1039/d0an02286a
ORCIDs: Castillo-León, Jaime , 0000-0003-2352-5726 , 0000-0002-6751-2305 and Svendsen, Winnie E.

DTU users get better search results including licensed content and discounts on order fees.

Log in as DTU user

Access

Analysis